Can the personalized medicine approach contribute in controlling tuberculosis in general and India in particular? | Zendy

Nikhat Khan | Zendy; Aparup Das | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Can the personalized medicine approach contribute in controlling tuberculosis in general and India in particular?

Author(s) -

Nikhat Khan,

Aparup Das

Publication year - 2020

Publication title -

precision clinical medicine

Language(s) - English

Resource type - Journals

eISSN - 2096-5303

pISSN - 2516-1571

DOI - 10.1093/pcmedi/pbaa021

Subject(s) - tuberculosis , isoniazid , personalized medicine , mycobacterium tuberculosis , medicine , principal (computer security) , precision medicine , intensive care medicine , traditional medicine , biology , bioinformatics , pathology , computer science , operating system

Poor drug compliance and drug-resistant Mycobacterium tuberculosis are the two principal obstacles in controlling tuberculosis (TB) in endemic regions including India, which has contributed the most to global TB burden. We argue here that a personalized medicine approach, to start with the N-acetyl transferase-2–isoniazid (NAT2–INH) model, could be a step forward in dealing with both these limitations in controlling TB in India.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research